• 2017 Research Roundup
  • Elise Landais 2017
  • EndAIDS4Good slider plain 1 

  • 11.9.17AtlanticLivePharm287 slider
  • tcell 620x305
  • Janssen Syringe
  • RESEARCH
    ROUNDUP 2017

    Read more
  • IAVI STUDY IN IMMUNITY
    MAPS POWERFUL
    ANTIBODY DEVELOPMENT
    IN STUDY VOLUNTEER

    Read more
  • FRAN PRIDDY
    TALKS SCIENTIFIC
    CHALLENGES
    AT VACCINE EVENT
    HOSTED BY
    THE ATLANTIC

    Read more
  • IAVI EXPLORES
    HIV-CANCER LINK

    Jonathan Hare at the Human Immunology Lab
    in London is teaming up with cancer scientists
    to investigate immunological similarities
    between cancer and HIV.

    Read more
  • IAVI CLINICAL NETWORK HELPS
    JANSSEN ASSESS PROMISING
    MOSAIC HIV VACCINE

    Read more

A Vaccine is Essential to a World Without AIDS Thumbnail

For Scientists

The Journal of AIDS Vaccine Research

IR Vol21No4 2017 CoverDo Pediatric Vaccines Stand a Better Chance of Protecting Against HIV?
A committee asks age-old questions about immunity as they set out to look at how the delicate and complex immune systems of infants and young children might help inform AIDS vaccine development. Read more

Most Recent Publications

Science for Non-Scientists

VAX has AIDS vaccine science for you.

VAX 1116 masthead

Annual Investment Trends in HIV Prevention Research and Development

Global preventive AIDS vaccine R&D investment totaled US$818 million in 2013, with the public sector providing US$666 million (81%), the philanthropic sector providing US$121 million (15%), and the commercial sector contributing US$31 million (4%). The 2013 total investment represents a decrease of US$29 million (4%) below global preventive AIDS vaccine R&D investment in 2012.

Continue Reading